Literature DB >> 15869720

Biomarkers for the detection and prognosis of prostate cancer.

Javier Hernandez1, Edith Canby-Hagino, Ian M Thompson.   

Abstract

Recent studies have cast doubt on the reliability of serum total prostate-specific antigen as a biomarker for the detection and prognosis of prostate cancer. Biomarkers that can identify those men at risk for clinically significant prostate cancer are desperately needed. The search for biomarkers that may improve the detection of biologically consequential prostate cancer is one of the most active areas under current investigation. In this review, we highlight some of these ongoing efforts. Proper validation of newly discovered biomarkers is of paramount importance.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15869720     DOI： 10.1007/s11934-005-0004-7

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN： 1527-2737            Impact factor:   2.862


  86 in total

Review 1.  Morphologic and molecular prognostic markers in prostate cancer.

Authors:  Jeffrey S Ross; Christine E Sheehan; Eric M Dolen; Bhaskar V S Kallakury
Journal:  Adv Anat Pathol       Date:  2002-03       Impact factor: 3.875

Review 2.  Familial prostate cancer.

Authors:  J L Stanford; E A Ostrander
Journal:  Epidemiol Rev       Date:  2001       Impact factor: 6.222

3.  Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma.

Authors:  H L Adler; M A McCurdy; M W Kattan; T L Timme; P T Scardino; T C Thompson
Journal:  J Urol       Date:  1999-01       Impact factor: 7.450

Review 4.  American Cancer Society Guidelines for the Early Detection of Cancer, 2005.

Authors:  Robert A Smith; Vilma Cokkinides; Harmon J Eyre
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

Review 5.  Diagnostic utility of alpha-methylacyl CoA racemase (P504S) on prostate needle biopsy.

Authors:  Zhong Jiang; Bruce A Woda
Journal:  Adv Anat Pathol       Date:  2004-11       Impact factor: 3.875

6.  An integrated approach utilizing artificial neural networks and SELDI mass spectrometry for the classification of human tumours and rapid identification of potential biomarkers.

Authors:  G Ball; S Mian; F Holding; R O Allibone; J Lowe; S Ali; G Li; S McCardle; I O Ellis; C Creaser; R C Rees
Journal:  Bioinformatics       Date:  2002-03       Impact factor: 6.937

Review 7.  Proteomic approaches within the NCI early detection research network for the discovery and identification of cancer biomarkers.

Authors:  M Verma; G L Wright; S M Hanash; R Gopal-Srivastava; S Srivastava
Journal:  Ann N Y Acad Sci       Date:  2001-09       Impact factor: 5.691

8.  A comprehensive endocrine description of Kennedy's disease revealing androgen insensitivity linked to CAG repeat length.

Authors:  S Dejager; H Bry-Gauillard; E Bruckert; B Eymard; F Salachas; E LeGuern; S Tardieu; R Chadarevian; P Giral; G Turpin
Journal:  J Clin Endocrinol Metab       Date:  2002-08       Impact factor: 5.958

9.  Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer.

Authors:  Jinong Li; Zhen Zhang; Jason Rosenzweig; Young Y Wang; Daniel W Chan
Journal:  Clin Chem       Date:  2002-08       Impact factor: 8.327

10.  The CAG repeat within the androgen receptor gene and its relationship to prostate cancer.

Authors:  E Giovannucci; M J Stampfer; K Krithivas; M Brown; D Dahl; A Brufsky; J Talcott; C H Hennekens; P W Kantoff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205
View more
  2 in total

1.  Selenium-responsive proteins in the sera of selenium-enriched yeast-supplemented healthy African American and Caucasian men.

Authors:  Raghu Sinha; Indu Sinha; Nicole Facompre; Stephen Russell; Richard I Somiari; John P Richie; Karam El-Bayoumy
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-19       Impact factor: 4.254

Review 2.  Human body fluid proteome analysis.

Authors:  Shen Hu; Joseph A Loo; David T Wong
Journal:  Proteomics       Date:  2006-12       Impact factor: 3.984
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.